August 12, 2019 by Chain Drug Review
AllianceRx Walgreens Prime, limited distribution drugs (LDDs), specialty medicines, Tracey James
Leading Headlines, Pharmacy
ORLANDO, Fla. — AllianceRx Walgreens Prime announced additional medicines available to patients with certain rare, chronic and complex conditions. Known as limited distribution drugs (LDDs), these specialty medicines treat certain types of multiple sclerosis (MS), Lambert-Eaton myasthenic syndrome (LEMS) and a form of non-Hodgkin’s lymphoma (NHL), among other complex conditions. Since last spring, the following
March 5, 2019 by Chain Drug Review
AllianceRx Walgreens Prime, National Association of Specialty Pharmacy (NASP), Rick Miller
Leading Headlines, Pharmacy
ORLANDO, Fla. — AllianceRx Walgreens Prime is sponsoring accredited, web-based continuing education (CE) customized specifically for members of the National Association of Specialty Pharmacy (NASP), which includes AllianceRx Walgreens Prime pharmacists. The CE content is accredited, managed and delivered through ProCE, a nationally recognized provider of CE for healthcare professionals. As part of its ongoing professional development and
February 28, 2019 by Chain Drug Review
AllianceRx Walgreens Prime, Dane Hallberg, Probuphine (buprenorphine), Titan Pharmaceuticals, Tracey James
Featured Articles, Leading Headlines, Pharmacy
SOUTH SAN FRANCISCO, Calif. — Titan Pharmaceuticals announced Thursday the execution of a specialty pharmacy distribution and services agreement with AllianceRx Walgreens Prime that will expand patient access to treatment with Probuphine (buprenorphine) implant, Titan’s unique six-month maintenance treatment for opioid use disorder (OUD) in eligible patients. Titan expects the majority of Probuphine sales in the
February 13, 2019 by Chain Drug Review
AllianceRx Walgreens Prime, Cyramza (ramucirumab), Epclusa (sofosbuvir/velpatasvir), Harvoni (ledipasvir/sofosbuvir), limited-distribution drugs, Nuzyra (omadacycline), Portrazza (necitumumab), Probuphine (buprenorphine), Tracey James, Ultomiris (ravulizumab-cwvz)
Leading Headlines, Pharmacy
ORLANDO, Fla. — AllianceRx Walgreens Prime, a leading central specialty and home delivery pharmacy, can now offer new medicines to patients with certain rare, chronic and complex conditions. Known as limited distribution drugs, these hard-to-find medicines treat rare conditions such as advanced cancer of the stomach, community-acquired bacterial pneumonia (CABP), and opioid addiction, to name a
January 11, 2019 by Chain Drug Review
AllianceRx Walgreens Prime, Joel Wright, Kylanne Green, URAC reaccreditation
Leading Headlines, Pharmacy
ORLANDO, Fla. — AllianceRx Walgreens Prime, a specialty and home delivery pharmacy, received reaccreditation from URAC for its specialty pharmacy services. URAC is the independent leader in promoting health care quality through accreditation, certification and measurement. By achieving this status, AllianceRx Walgreens Prime has demonstrated a comprehensive commitment to quality care, improved processes and better patient outcomes.
December 5, 2018 by Chain Drug Review
AllianceRx Walgreens Prime, John Stephens
Leading Headlines, Pharmacy
ORLANDO, Fla. — Prescription drug coverage benefits can be confusing at times. However, nearly half of all adults take steps to manage their drug benefit before the new year, according to a survey conducted by leading specialty and home delivery pharmacy AllianceRx Walgreens Prime. The survey also found room for improvement and many ways people can
November 19, 2018 by Chain Drug Review
AllianceRx Walgreens Prime, Amicus Therapeutics, Doptelet (avatrombopag), Dova Pharmaceuticals, Galafold (Migalastat), Inc., Joel Wright, Leadiant Biosciences, Pfizer, Pharming Healthcare Inc., Revcovi (elapegademase-lvlr), Ruconest (C1 esterase inhibitor [recombinant]), Talzenna (talazoparib), Vizimpro (dacomitnib), Zavesca (miglustat)
Leading Headlines, Pharmacy, Retail News
ORLANDO, Fla. — Patients with certain rare, chronic and complex conditions can now obtain the medications that may improve or save their lives from AllianceRx Walgreens Prime, a leading central specialty and home delivery pharmacy. The hard-to-find drugs, called limited distribution drugs, treat such rare conditions as metastatic breast cancer, chronic liver disease, metastatic non-small cell
October 30, 2018 by Chain Drug Review
AllianceRx Walgreens Prime, Joel Wright, Marcelie "Tuck" Tucker
Leading Headlines, Pharmacy, Retail News
ORLANDO, Fla. — AllianceRx Walgreens Prime, a leading specialty and home delivery pharmacy, has named Marcelie “Tuck” Tucker as chief human resources officer. Tucker, who was most recently vice president of human resources with Dover Corporation’s refrigeration and food equipment segment, will join the executive leadership team based in the company’s Orlando headquarters. Tucker joins
July 24, 2018 by Chain Drug Review
AllianceRx Walgreens Prime, Kylanne Green, specialty and home delivery pharmacy, URAC
Featured Articles, Leading Headlines, Pharmacy, Retail News
ORLANDO, Fla. — AllianceRx Walgreens Prime, a combined specialty and home delivery pharmacy, has received Mail Service Pharmacy Accreditation from URAC for its home delivery pharmacy services. URAC is a health care accrediting organization based in Washington, D.C. that establishes quality standards for the health care industry. AllianceRx Walgreens Prime earned fully accredited status in the
June 26, 2018 by Chain Drug Review
AllianceRx Walgreens Prime, Inovalon, Inovalon ONE Platform, Joel Wright, Keith Dunleavy
Featured Articles, Leading Headlines, Pharmacy, Retail News
ORLANDO, Fla. — AllianceRx Walgreens Prime, the combined central specialty and home delivery pharmacy formed by Walgreens and pharmacy benefit manager Prime Therapeutics LLC (Prime) announced today a collaboration with Inovalon, a leading technology company providing cloud-based platforms empowering data-driven healthcare. Under the agreement, Inovalon will implement ScriptMed Cloud, a specialized configuration of the Inovalon ONE
April 26, 2018 by Chain Drug Review
AllianceRx Walgreens Prime, Austedo, Fasenra, Hemlibra, Joel Wright, Symdeko, Walgreens
Leading Headlines, Pharmacy, Retail News
ORLANDO, Fla. and DEERFIELD, Ill.—AllianceRx Walgreens Prime, the combined central specialty and home delivery pharmacy formed by Walgreens and pharmacy benefit manager Prime Therapeutics LLC (Prime), and Walgreens, announce the availability of several new limited distribution drugs for its specialty patients. The new drugs treat rare conditions such as Huntington’s disease, severe asthma and cystic
March 28, 2018 by Bill Schiffner
AllianceRx Walgreens Prime, Rite Aid, Stefano Pessina, Walgreens Boots Alliance
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) reported better-than-expected earnings and revenue on Wednesday when it announced results for the second quarter of fiscal 2018, which ended February 28. Overall, WBA earned $1.73 a share, up 27% versus a year ago. Revenue grew 12.1% to $33.02 billion. Same-store sales rose 2.4%, with comparable-pharmacy sales up
February 12, 2018 by Mark Baumgartner and Chain Drug Review
AllianceRx Walgreens Prime, Rick Miller, Walgreens, Walgreens Connected Care Oncology
2018, Issue 02-12-2018, Issues, News
DEERFIELD, Ill. — Walgreens has received a U.S. patent for new proprietary technology that its Walgreens community specialty pharmacists and AllianceRx Walgreens Prime’s specialty pharmacists will use to facilitate communication with and counseling of individuals prescribed oral oncology medicines. The technology will be applied through Walgreens Connected Care Oncology, a process that helps pharmacy customers
January 30, 2018 by Chain Drug Review
Aetna, AllianceRx Walgreens Prime, Amazon, Berkshire Hathaway, Brian Tanquilut, CVS Health, employee health care, employee health care partnership, EnvisionRxOptions, Health Dialog, Health Transformation Alliance, HTA, Jaimie Dimon, Jeff Bezo, JPMorgan Chase, Prime Therapeutics, Rite Aid, Walgreens Boots Alliance, Warren Buffet
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News
NEW YORK — Three of the largest U.S. companies — Berkshire Hathaway, Amazon and JPMorgan Chase & Co. — have joined together to take employee health care into their own hands. Berkshire Hathaway, Amazon and JPMorgan Chase said Tuesday that they plan to form an independent health care company to provide their employees accessible, affordable and quality care.